Company

About

Aros Applied Biotechnology

Aros Applied Biotechnology

Aarhus, Denmark

Eurofins Genomics was founded in 1990 and is part of the Eurofins Scientific Group, a Life Science Company with laboratories in 61 countries and 61,000 employees. We are an international provider of genomic services around the core business lines next generation sequencing, genotyping, gene expression, custom DNA sequencing, oligonucleotides, siRNA and gene synthesis. Our services are tailored for pharma, diagnostics, agriculture, food, biotechnology and research applications worldwide. Imprint: https://www.eurofinsgenomics.eu/imprint/ Privacy Note: https://www.eurofinsgenomics.eu/privacy/

Neumirna Therapeutics

Neumirna Therapeutics

A.C. Meyers Vænge 15, Copenhagen, Capital Region of Denmark 2450, DK

Developing RNA therapeutics for disease modification neurological disorders

Pentabase

Pentabase

Odense, Denmark

PentaBase is a knowledge-based Danish pharmacogenomics company founded and managed by researchers and located in the heart of Denmark. We specialise in custom oligonucleotide production and the development of in vitro diagnostic assays for real-time PCR with a special focus on the detection of somatic mutations in cancer and COVID-19. For more than 10 years, PentaBase has created products for researchers and medical professionals exploring new treatments and helping patients worldwide. Our products are given unique abilities in the analysis and manipulation of genetic material with our proprietary technology, INAs® (Intercalating Nucleic Acids). Medical professionals and researchers use these features to help treat diseases and acquire new knowledge. We believe in open-platform designs and strive to make our products compatible with basic instruments used in molecular biology facilities worldwide. For more information, please contact us at: Tel: +45 3696 9496 Mail: info@pentabase.com https://www.pentabase.com/

Radiomer Therapeutics

Radiomer Therapeutics

Åkandevej 21, 2700 Brønshøj, Denmark

Radiomer Therapeutics, Inc. is a Fannin-founded company that is developing targeted radiopharmaceuticals for cancer treatment.